国际妇产科学杂志

国际妇产科学杂志 ›› 2012, Vol. 39 ›› Issue (3): 254-256.

• 综述 • 上一篇    下一篇

卵巢交界性肿瘤治疗进展

武丽蕊,姜 岩   

  1. 065000 河北省廊坊市,中国石油中心医院妇产科
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2012-06-15 发布日期:2012-06-15
  • 通讯作者: 武丽蕊

Advances in Therapy of Borderline Ovarian Tumors

WU Li-rui，JIANG Yan   

  1. Department of Gynecology and Obstetrics，China National Petroleum Company Central Hospital，Hebei Langfang 065000，China
  • Received:1900-01-01 Revised:1900-01-01 Published:2012-06-15 Online:2012-06-15
  • Contact: WU Li-rui

PDF (PC)

4847

摘要： 卵巢交界性肿瘤（BOT）占卵巢上皮性肿瘤的10%～20%，其生物学行为介于卵巢良性肿瘤与恶性浸润性肿瘤之间，为低度恶性卵巢肿瘤。近年来，国内外学者认为大多数患者接受了过度治疗。主张对部分有生育要求的年轻患者行保守性手术治疗。目前对于BOT的治疗尚无明确的标准和治疗规范，在具体的临床实践中，仍存在许多问题及争议。就BOT在手术治疗（全面分期手术、保守性手术、再分期手术、腹腔镜手术的应用）、术后辅助治疗以及复发后治疗方面进行综述。

关键词: 卵巢肿瘤, 抗肿瘤联合化疗方案, 腹腔镜检查, 预后, 治疗

Abstract: The borderline ovarian tumors（BOT）cover 10%-20% in epithelial ovarian tumors. The biological behaviour of BOT is between benign neoplasm and malignant tumor. They were low malignant tumors. In recently years，the scholars from domeslic and overseas considered that most of the BOT patients received excessive therapy. They think that patients who want pregnancy can have a conservative surgery. About the therapy of the BOT，there are many problems because of without accord criterion. We reviewed the staging surgery，conservative surgery，restaging surgery，laparoscopy and adjuvant therapy of BOT.

Key words: Ovarian neoplasms, Antineoplastic combined chemotherapy protocols, Laparoscopy, Prognosis, Therapy